Dissemination of the Clinical Practice Guideline entitled Complementary and
Dissemination of the Clinical Practice Guideline entitled Complementary and
批准号:
8468563
负责人:
Pushpa Narayanaswami
金额:
$19.02万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-05-08 至 2014-10-31
中文摘要
描述(由申请人提供):循证临床实践指南是针对特定临床问题或疑问提供优化患者护理建议的声明。然而,仅仅阅读一项准则的行为很少导致建议的执行,因此需要积极传播。美国神经病学学会(AAN)有一个正式的指南制定和向医生和患者传播的过程。社交媒体的作用(Facebook,Twitter等)和更新的传播方式(播客、网络研讨会等)在指导方针中,没有研究传播。AAN目前正在制定一项名为“多发性硬化症(MS)中的补充和替代医学(CAM)”的循证指南,以提出关于CAM在MS中的安全性和有效性的建议。这一主题非常重要,因为CAM经常被MS患者使用,他们很少与医生讨论他们使用CAM的情况。目的:具体目标1:制定一项新的、创新的传播战略,将传统(目前使用的方法)和更新的方法结合起来,用于题为“MS中的CAM”的指南。具体目标2:通过过程和结果措施衡量传播战略的有效性。具体目标3:比较不同传播方法在不同目标受众中的效果,以评估对每一受众的最佳传播方法。该提案涉及两个AHRQ研究组合:患者安全和创新/新出现的问题,以及AHRQ优先考虑有特殊医疗保健需求的个人。它符合太平洋地区保健改革研究所的研究问题:评估保健服务系统干预措施的好处,并解决个体差异和执行和传播障碍。研究方法:传播计划将包括一项传播前调查,以确定问题并确定受众、护理差距、实施障碍和传播机会。传播战略将利用传统和非传统的创新方法。在传播指南后,将使用过程测量来评估该策略的有效性:指南覆盖了多少患者和医生?和成果计量:实践模式的变化:即,医生是否开始定期询问患者CAM的使用情况?患者是否改变了CAM的使用?最后,将对每一种传播方法和每一个目标对象的过程和结果措施进行评价。结论:这项研究的结果有很强的影响,未来的传播工作,以证据为基础的指南一般通过确定有效的传播方法,有效地利用资源。从该项目中吸取的经验教训将影响一般指南传播方法模型的开发。
英文摘要
DESCRIPTION (provided by applicant): Evidence-based clinical practice guidelines are statements that provide recommendations to optimize patient care for a specific clinical problem or question. However, the mere act of reading a guideline rarely leads to implementation of recommendations, and active dissemination is required. The American Academy of Neurology (AAN) has a formal process of guideline development and dissemination to physicians and patients. The role of social media (face book, twitter, etc.) and newer methods of dissemination (podcasts, webinars etc.) in guideline dissemination has not been studied. The AAN is currently developing an evidence- based guideline entitled "Complementary and Alternative Medicine (CAM) in multiple sclerosis (MS)" to make recommendations regarding the safety and efficacy of CAM in MS. This topic is very important because CAM is frequently used by MS patients, who seldom discuss their use of CAM with their physicians. Objectives: Specific Aim 1: To institute a new, innovative dissemination strategy combining traditional (presently used methods) and newer methods for the guideline entitled "CAM in MS". Specific Aim 2: To measure the effectiveness of the dissemination strategy by process and outcome measures. Specific Aim 3: To compare the effectiveness of different methods of dissemination in different target audiences in order to evaluate the best methods of dissemination for each audience. This proposal addresses two AHRQ portfolios of research: patient safety and innovations/emerging issues, and the AHRQ priority population of individuals with special health care needs. It is in keeping with PCORI's research questions: to assess the benefits of health delivery system interventions and to address individual differences and barriers to implementation and dissemination. Methods: The dissemination plan will include a pre- dissemination survey to define the problem and identify the audience, gaps in care, implementation barriers, and dissemination opportunities. The dissemination strategy will utilize both traditional and non-traditional, innovative methods. Having disseminated the guideline, the effectiveness of the strategy will be evaluated using process measures: how many patients and physicians did the guideline reach? and outcome measures: change in practice patterns: i.e., did physicians start asking patients regularly about CAM use? Did patients make changes in CAM use? Finally, the process and outcome measures will be evaluated for each dissemination method, and for each target audience. Conclusion: The results of this study have strong implications for future dissemination efforts for evidence based guidelines in general by identifying effective dissemination methods that utilize resources efficiently and effectively. Lessons learned from this project will influenc the development of models for guideline dissemination methods in general.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CLINICAL TRIAL: RITUXIMAB IN REFRACTORY ADULT AND JUVENILE MYOSITIS
-
批准号:7718918
-
项目类别:
-
资助金额:$0.2万
-
财政年份:2008
-
负责人:Pushpa Narayanaswami
-
依托单位:
RITUXIMAB IN REFRACTORY ADULT AND JUVENILE MYOSITIS
-
批准号:7606967
-
项目类别:
-
资助金额:$0.65万
-
财政年份:2007
-
负责人:Pushpa Narayanaswami
-
依托单位:
国内基金
海外基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
-
批准号:31070748
-
项目类别:面上项目
-
资助金额:34.0万元
-
批准年份:2010
-
负责人:Christine Nardini
-
依托单位: